EMPEROR-Preserved: Empagliflozin and Outcomes in Heart Failure with a Preserved Ejection Fraction and Chronic Kidney Disease

被引：0
|
作者：
Wanner, Christoph [1 ]
机构：
[1] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
来源：
INTERNIST | 2022年 / 63卷 / SUPPL 3期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PS083
引用
收藏
页码：349 / 349
页数：1
相关论文
共 50 条
  • [1] EMPEROR-Preserved: Empagliflozin and Outcomes in Heart Failure with a Preserved Ejection Fraction and CKD
    Zannad, Faiez
    Kraus, Bettina J.
    Zeller, Cordula
    Pocock, Stuart
    Packer, Milton
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Anker, Stefan D.
    Butler, Javed
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B3 - B3
  • [2] Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
    Boehm, Michael
    Anker, Stefan
    Mahfoud, Felix
    Lauder, Lucas
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Brueckmann, Martina
    Saloustros, Ilias
    Schueler, Elke
    Wanner, Christoph
    Zannad, Faiez
    Packer, Milton
    Butler, Javed
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (05) : 396 - 407
  • [3] Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved
    Coats, Andrew J. S.
    Butler, Javed
    Tsutsui, Hiroyuki
    Doehner, Wolfram
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Boehm, Michael
    Chopra, Vijay K.
    Verma, Subodh
    Nordaby, Matias
    Iwata, Tomoko
    Nitta, Daisuke
    Ponikowski, Piotr
    Zannad, Faiez
    Packer, Milton
    Anker, Stefan D.
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (01) : 412 - 424
  • [4] Uric Acid and Treatment With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial
    Doehner, Wolfram
    [J]. CIRCULATION, 2022, 146
  • [5] Association of heart rate with heart failure outcomes and the effects of empagliflozin in patients with preserved ejection fraction - EMPEROR-Preserved trial
    Boehm, M.
    Anker, S. D.
    Mahfoud, F.
    Filippatos, G.
    Ferreira, J. P.
    Pocock, S. J.
    Brueckmann, M.
    Linetzky, B.
    Schueler, E.
    Wanner, C.
    Zannad, F.
    Packer, M.
    Butler, J.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 983 - 983
  • [6] Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction EMPEROR-Preserved Trial
    Packer, Milton
    Butler, Javed
    Zannad, Faiez
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Carson, Peter
    Anand, Inder
    Doehner, Wolfram
    Haass, Markus
    Komajda, Michel
    Miller, Alan
    Pehrson, Steen
    Teerlink, John R.
    Schnaidt, Sven
    Zeller, Cordula
    Schnee, Janet M.
    Anker, Stefan D.
    [J]. CIRCULATION, 2021, 144 (16) : 1284 - 1294
  • [7] Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial
    Butler, Javed
    Siddiqi, Tariq Jamal
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Zannad, Faiez
    Anker, Stefan D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (02) : 245 - 248
  • [8] Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial
    Boehm, Michael
    Butler, Javed
    Krawczyk, Marcin
    Mahfoud, Felix
    Haring, Bernhard
    Filippatos, Gerasimos
    Ferreira, Joao Pedro J.
    Pocock, Stuart
    Brueckmann, Martina
    Ofstad, Anne Pernille
    Schueler, Elke
    Wanner, Christoph
    Verma, Subodh
    Packer, Milton D.
    Anker, Stefan
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (08) : 1375 - 1383
  • [9] EMPAGLIFLOZIN IN HEART FAILURE WITH A PRESERVED EJECTION FRACTION ≥50%: RESULTS FROM THE EMPEROR-PRESERVED CLINICAL TRIAL
    Yousef, Zaheer
    [J]. HEART, 2022, 108 : A79 - A80
  • [10] Uric Acid and Treatment With Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF): the EMPEROR-Preserved Trial
    Green, Jennifer
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142 : S25 - S25
12345